Halozyme Therapeutics shares owned by Archford Capital Strategies
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Archford Capital Strategies
from 13F filings
Historical chart of Archford Capital Strategies investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Halozyme Therapeutics by Archford Capital Strategies
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $298k | 4.1k | 73.34 |
More positions owned by Archford Capital Strategies
View all positions for Archford Capital Strategies